Opportunity Information: Apply for CDC RFA DP14 141803CONT16

  • The HHS-CDC in the health sector is offering a public funding opportunity titled "National Implementation and Dissemination for Chronic Disease Prevention" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.328.
  • This funding opportunity was created on Mar 29, 2016 and posted on Mar 29, 2016.
  • Applicants must submit their applications by Apr 29, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
Apply for CDC RFA DP14 141803CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The grant opportunity titled "National Implementation and Dissemination for Chronic Disease Prevention" is a continuation funding announcement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (HHS-CDC). It is identified by the funding opportunity number CDC RFA DP14 141803CONT16 and is positioned within the health funding activity category. The focus, as stated in the title and brief description, is on supporting ongoing national-level work that helps implement and spread (disseminate) approaches for chronic disease prevention. In practical terms, this kind of opportunity typically supports efforts that move proven prevention strategies into broader, real-world use, rather than small pilot projects that remain limited to a single site or community.

This announcement uses a cooperative agreement as the funding instrument type. A cooperative agreement generally signals that the CDC expects to have substantial involvement in the work beyond simply providing funds, such as collaborating on program direction, providing technical assistance, aligning evaluation and performance measures, supporting dissemination strategies, and ensuring the project remains consistent with federal priorities. Because the opportunity is labeled as continuation funding, it is aimed at extending or continuing previously funded work under an existing project or program rather than launching entirely new awards open to all new entrants. The listing does not specify a number of expected awards, and the award ceiling is shown as 0, which commonly indicates that a specific maximum award amount is not provided in this record summary or that funding levels are determined by the continuation context and the approved budget within the existing project period.

The CFDA number associated with the opportunity is 93.328, which is the catalog identifier used to track federal assistance programs. The eligible applicants field is listed as "Others," with a note to refer to an additional eligibility section for clarification. That wording often means eligibility may be restricted to certain organizations, potentially including current recipients under the underlying program, specific types of national organizations, or other entities meeting criteria laid out in the full funding opportunity announcement. Since this is continuation funding, eligibility is frequently limited to existing awardees or a defined set of partners already working with CDC under the relevant cooperative agreement.

Key dates in the record show that the opportunity was created and posted on March 29, 2016, with an original and current closing date of April 29, 2016. The matching original and current closing dates indicate there were no extensions or amendments to the deadline reflected in this summary. Overall, the announcement is best understood as a CDC continuation cooperative agreement mechanism intended to maintain and advance national implementation and dissemination activities that prevent chronic disease, leveraging established program infrastructure and CDC collaboration to extend reach, adoption, and consistent use of evidence-based prevention approaches.

Frequently Asked Questions (FAQs)

What is the title of this grant opportunity?

The opportunity is titled National Implementation and Dissemination for Chronic Disease Prevention.

Which agency is offering this funding opportunity?

This is a continuation funding announcement from the U.S. Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC).

What is the funding opportunity number?

The funding opportunity number is CDC RFA DP14 141803CONT16.

What type of funding instrument is being used?

The instrument type is a cooperative agreement.

What does it mean that this is a cooperative agreement?

A cooperative agreement generally indicates that CDC expects to be substantially involved in the funded work, beyond providing funds. Based on the summary provided, that involvement may include collaboration on program direction, technical assistance, alignment on evaluation and performance measures, support for dissemination strategies, and helping ensure the work stays consistent with federal priorities.

What is the main focus of this opportunity?

The focus is to support ongoing national-level work that helps implement and disseminate approaches for chronic disease prevention.

What does "implementation and dissemination" mean in this context?

In practical terms, the summary describes work that helps move proven prevention strategies into broader real-world use at a national level, rather than limiting efforts to small pilot projects in a single site or community.

Is this funding meant for new projects or continuing work?

This is described as continuation funding, meaning it is intended to extend or continue previously funded work under an existing project or program rather than launch entirely new awards open to all new entrants.

Who is eligible to apply?

The eligible applicants field is listed as "Others", with a note to refer to an additional eligibility section for clarification. The summary also suggests that, because this is continuation funding, eligibility is often limited to existing awardees or a defined set of partners already working with CDC under the relevant cooperative agreement.

Does this summary confirm that only current awardees can apply?

No. The summary does not provide the detailed eligibility criteria. It indicates eligibility may be restricted and points to an additional eligibility section in the full announcement for clarification.

What is the CFDA number for this opportunity?

The CFDA number is 93.328, which is the catalog identifier used to track federal assistance programs.

What is the activity category for this opportunity?

It is positioned within the health funding activity category.

When was the opportunity posted?

The record shows the opportunity was created and posted on March 29, 2016.

What is the application deadline?

The original and current closing date shown in the record is April 29, 2016.

Was the deadline extended?

No extension is reflected in the summary. The original and current closing dates match, which indicates no extensions or amendments to the deadline were reflected in this record summary.

How many awards does CDC expect to make?

The listing does not specify a number of expected awards.

Is there an award ceiling (maximum funding amount)?

The award ceiling is shown as 0 in this record summary. As described, that commonly indicates a specific maximum award amount is not provided in the summary or that funding levels are determined by the continuation context and the approved budget within the existing project period.

What kinds of activities is this continuation award intended to support?

Based on the summary, it is intended to maintain and advance national implementation and dissemination activities that prevent chronic disease, leveraging established program infrastructure and CDC collaboration to extend reach, adoption, and consistent use of evidence-based prevention approaches.

Does the summary include details on required deliverables, budget limits, or evaluation requirements?

No. The summary mentions CDC involvement in areas like evaluation and performance measures, but it does not provide specific deliverables, budget limitations, or detailed evaluation requirements.

Browse more business programs for Chronic Disease Research

Browse more opportunities from the same agency: HHS-CDC

Browse more opportunities from the same category: Health

Next opportunity: Program for Investment in Microentrepreneurs (PRIME)

Previous opportunity: Prevention Innovation Program III (PIP) (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for CDC RFA DP14 141803CONT16

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (CDC RFA DP14 141803CONT16) also looked into and applied for these:

Funding Opportunity
Strategic Prevention Framework for Prescription Drugs (SPF Rx) Apply for SP 16 006

Funding Number: SP 16 006
Agency: HHS-SAMHS
Category: Health
Funding Amount: $371,616
Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths (PDO) Apply for SP 16 005

Funding Number: SP 16 005
Agency: HHS-SAMHS
Category: Health
Funding Amount: $11,000,000
Partnerships for Countermeasures against Select Pathogens (R01) Apply for RFA AI 16 034

Funding Number: RFA AI 16 034
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
HPV Roundtable: Creating a National Network of Partners to Promote Cancer Prevention through Human Papillomavirus Vaccination- Financed in Part by 2016 Prevention and Public Health Funds Apply for CDC RFA IP16 1602PPHF16

Funding Number: CDC RFA IP16 1602PPHF16
Agency: HHS-CDC-NCIRD
Category: Health
Funding Amount: $500,000
New Technologies for the Glycosciences (R41/R42) Apply for PA 16 158

Funding Number: PA 16 158
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Cooperative Agreements for Tribal Behavioral Health Apply for SM 16 010

Funding Number: SM 16 010
Agency: HHS-SAMHS
Category: Health
Funding Amount: $200,000
New Technologies for the Glycosciences (R43/R44) Apply for PA 16 157

Funding Number: PA 16 157
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
Adult Maturational Changes and Dysfunctions in Emotion Regulation (R21) Apply for RFA MH 17 400

Funding Number: RFA MH 17 400
Agency: HHS-NIH11
Category: Health
Funding Amount: $200,000
Dental Faculty Development and Loan Repayment Program Apply for HRSA 16 182

Funding Number: HRSA 16 182
Agency: HHS-HRSA
Category: Health
Funding Amount: Case Dependent
Advancing National Public Health Institutes Globally Apply for CDC RFA GH14 141903CONT16

Funding Number: CDC RFA GH14 141903CONT16
Agency: HHS-CDC
Category: Health
Funding Amount: Case Dependent
Support for Public Health Drinking Water Programs to Improve Efficiency & Effectiveness for Controlling Drinking Water Exposures Apply for CDC RFA EH15 150702CONT16

Funding Number: CDC RFA EH15 150702CONT16
Agency: HHS-CDC
Category: Health
Funding Amount: Case Dependent
Tribal Public Health Capacity Building and Quality Improvement Apply for CDC RFA OT13 130304CONT16

Funding Number: CDC RFA OT13 130304CONT16
Agency: HHS-CDC
Category: Health
Funding Amount: Case Dependent
NIH Director's Transformative Research Awards (R01) Apply for RFA RM 16 007

Funding Number: RFA RM 16 007
Agency: HHS-NIH11
Category: Health
Funding Amount: Case Dependent
NIH Director's New Innovator Award Program (DP2) Apply for RFA RM 16 004

Funding Number: RFA RM 16 004
Agency: HHS-NIH11
Category: Health
Funding Amount: $1,500,000
NIH Pioneer Award Program (DP1) Apply for RFA RM 16 005

Funding Number: RFA RM 16 005
Agency: HHS-NIH11
Category: Health
Funding Amount: $700,000
Comprehensive Health Services Delivery (CHSD) Apply for RFA 621 16 000012

Funding Number: RFA 621 16 000012
Agency: USAID-TAN
Category: Health
Funding Amount: $325,211,110
Capacity building for ecological surveillance of viral hemorrhagic fevers in Sierra Leone Apply for CDC RFA CK16 1605

Funding Number: CDC RFA CK16 1605
Agency: HHS-CDC-NCEZID
Category: Health
Funding Amount: Case Dependent
Program Supplements for Violence Intervention to Enhance Lives (Short Title: VITEL) Apply for TI 16 010

Funding Number: TI 16 010
Agency: HHS-SAMHS
Category: Health
Funding Amount: $70,000
Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) Apply for PA 16 163

Funding Number: PA 16 163
Agency: HHS-NIH11
Category: Health
Funding Amount: $100,000
Emerging Infections Programs Apply for CDC RFA CK17 1701

Funding Number: CDC RFA CK17 1701
Agency: HHS-CDC-NCEZID
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DP14 141803CONT16", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.